Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$18.57

0.89 (5.03%)

12:05
10/03/16
10/03
12:05
10/03/16
12:05

Exact Sciences rises after NCQA updates colorectal cancer screening measure

Reference Link

  • 04

    Oct

  • 26

    Oct

  • 15

    Nov

EXAS Exact Sciences
$18.57

0.89 (5.03%)

08/10/16
BARD
08/10/16
NO CHANGE
BARD
Outperform
HCSC coverage of Cologuard could pressure other payors, says Baird
Baird analyst Catherine Ramsey noted that Health Care Service Corporation, or HCSC, which is the nation's largest customer-owned health insurance company as the owner of several Blue Cross and Blue Shield systems, has posted a pending medical policy that would provide coverage for Exact Sciences' Cologuard. Coverage of the test by HCSC would be a "significant win" and could help pressure other payors to update their policies, said Ramsey, who keeps an Outperform rating on Exact Sciences shares.
08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.

TODAY'S FREE FLY STORIES

XLY

Consumer Discretionary Sector SPDR

$89.13

-0.71 (-0.79%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.68

-0.33 (-0.61%)

08:19
06/28/17
06/28
08:19
06/28/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$52.97

-0.6 (-1.12%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.23

-0.48 (-0.86%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

, AET

Aetna

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Interpace Diagnostics announces national contract with Aetna »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$0.85

-0.043 (-4.82%)

AET

Aetna

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBIO

Catalyst Biosciences

$4.47

-0.07 (-1.54%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Hot Stocks
Catalyst granted orphan product designation for hemophilia B candidate in Europe »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLV

Health Care Select Sector SPDR

$79.66

-0.73 (-0.91%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$139.84

-1.24 (-0.88%)

08:18
06/28/17
06/28
08:18
06/28/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$212.93

-0.94 (-0.44%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$241.33

-1.96 (-0.81%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.14

0.12 (0.50%)

08:17
06/28/17
06/28
08:17
06/28/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$82.90

-2.44 (-2.86%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$53.69

-0.86 (-1.58%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Hot Stocks
Ingevity to construct activated carbon extrustion plant in China »

Ingevity Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

QQQ

PowerShares QQQ Trust

$138.03

-2.55 (-1.81%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$5,671.60

-105.98995 (-1.83%)

08:16
06/28/17
06/28
08:16
06/28/17
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$14.45

-0.45 (-3.02%)

08:15
06/28/17
06/28
08:15
06/28/17
08:15
Hot Stocks
CytomX Therapeutics treats first patient in Phase 1/2 PROCLAIM-CX-2009 trial »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
Energy Action: NYMEX »

Energy Action: NYMEX…

08:15
06/28/17
06/28
08:15
06/28/17
08:15
General news
International Trade in Goods Balance to be reported at 08:30 »

May International Trade…

LNCE

Snyder's-Lance

$34.88

-1.27 (-3.51%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Hot Stocks
Snyder's-Lance appoints Brian Driscoll as CEO »

Snyder's-Lance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto sees FY17 ongoing EPS $4.50-$4.90, consenus $4.89 »

The company confirms EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

, BAYRY

Bayer

$137.59

0.89 (0.65%)

08:14
06/28/17
06/28
08:14
06/28/17
08:14
Earnings
Monsanto reports Q3 ongoing EPS $1.93, consensus $1.76 »

Reports Q3 revenue…

MON

Monsanto

$117.25

-0.55 (-0.47%)

BAYRY

Bayer

$137.59

0.89 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

08:13
06/28/17
06/28
08:13
06/28/17
08:13
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$27.50

-0.4 (-1.43%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Hot Stocks
Global Blood Therapeutics receives EMA PRIME designation for GBT440 »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNF

UniFirst

$139.05

-1.25 (-0.89%)

08:12
06/28/17
06/28
08:12
06/28/17
08:12
Earnings
UniFirst sees FY17 EPS $4.85-$5.00, consensus $5.01 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.